查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1609833

2024-2032 年日本临床试验管理系统市场报告（按组件、部署模式、最终用户和地区）

Japan Clinical Trials Management System Market Report by Component, Deployment Mode, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 115 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2023年日本临床试验管理系统市场IMARC Group达1.0638亿美元。临床试验的复杂性日益普遍，涉及更大的数据集、多个研究地点和复杂的监管要求，加上对简化试验管理和确保合规性的系统解决方案的需求不断增长，主要推动了市场的发展。

临床试验管理系统（CTMS）是一个全面的软体解决方案，用于优化和简化医学研究领域临床试验的管理。它是研究人员、申办者和研究协调员规划、执行和监控临床试验各个方面的集中平台。 CTMS 促进高效的参与者招募、追踪法规遵循、管理预算和资源，并产​​生即时报告以做出明智的决策。它还增强了利害关係人之间的沟通和协作，实现无缝资料共享和试验活动记录。 CTMS 的主要功能通常包括方案管理、病患登记和随机化、就诊安排、资料收集、不良事件追踪和财务管理。这些系统对于确保资料准确性、方案遵守和法规遵循至关重要，最终加速药物开发流程并提高病患安全。总之，CTMS 透过提供集中且有组织的试验管理、资料收集和报告方法，从而推动医学研究和医疗保健创新，在临床试验的成功执行中发挥关键作用。

日本临床试验管理系统市场趋势：

在多种因素的推动下，日本的临床试验管理系统市场目前正经历显着成长。首先，临床试验日益复杂，需要先进的 CTMS 解决方案。因此，製药和生技公司正在采用这些系统来简化试验流程，提高效率并降低营运成本。此外，临床研究中对资料整合和即时分析的日益重视也刺激了 CTMS 的采用。因此，CTMS 解决方案可与电子健康记录 (EHR) 和其他医疗资料来源无缝集成，促进试验期间更好的数据驱动决策。此外，监管机构提出了严格的合规要求，使得组织必须保持准确和最新的试验记录。 CTMS 平台提供资料和文件的集中储存库，确保合规性并促进稽核。此外，临床试验的区域扩张和虚拟试验的兴起增加了对具有强大远端监控和患者参与功能的系统的需求，预计将在预测期内推动日本临床试验管理系统市场的发展。

日本临床试验管理系统市场区隔：

组件见解：

  • 软体
  • 服务

部署模式见解：

  • 网路为基础的 CTMS
  • 本地
  • 基于云端的CTMS

最终使用者见解：

  • 製药和生物技术公司
  • 合约研究组织
  • 其他的

竞争格局：

市场研究报告也对市场竞争格局进行了全面分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外，也提供了所有主要公司的详细资料。

本报告回答的关键问题：

  • 日本临床试验管理系统市场迄今表现如何，未来几年将如何表现？
  • COVID-19 对日本临床试验管理系统市场有何影响？
  • 日本临床试验管理系统市场以组件划分是怎样的？
  • 日本临床试验管理系统市场依部署模式划分是怎样的？
  • 日本临床试验管理系统市场以最终用户划分是怎样的？
  • 日本临床试验管理系统市场价值链的各个阶段是什么？
  • 日本临床试验管理系统的关键驱动因素与挑战是什么？
  • 日本临床试验管理系统市场的结构如何？
  • 日本临床试验管理系统市场的竞争程度如何？

本报告回答的关键问题：

  • 日本临床试验管理系统市场迄今表现如何，未来几年将如何表现？
  • COVID-19 对日本临床试验管理系统市场有何影响？
  • 日本临床试验管理系统市场以组件划分是怎样的？
  • 日本临床试验管理系统市场依部署模式划分是怎样的？
  • 日本临床试验管理系统市场以最终用户划分是怎样的？
  • 日本临床试验管理系统市场价值链的各个阶段是什么？
  • 日本临床试验管理系统的关键驱动因素与挑战是什么？
  • 日本临床试验管理系统市场的结构如何？
  • 日本临床试验管理系统市场的竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：日本临床试验管理系统市场 - 简介

  • 概述
  • 市场动态
  • 产业动态
  • 竞争情报

第 5 章：日本临床试验管理系统市场格局

  • 历史与当前市场趋势（2018-2023）
  • 市场预测（2024-2032）

第 6 章：日本临床试验管理系统市场 - 细分：按组成部分

  • 软体
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 服务
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）

第 7 章：日本临床试验管理系统市场 - 细分：依部署模式

  • 网路为基础的 CTMS
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 本地
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 基于云端的CTMS
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）

第 8 章：日本临床试验管理系统市场 - 细分：依最终使用者划分

  • 製药和生物技术公司
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 合约研究组织
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 其他的
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）

第 9 章：日本临床试验管理系统市场 - 竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳制胜策略
  • 竞争仪表板
  • 公司评估象限

第 10 章：关键参与者简介

  • Company A
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第 11 章：日本临床试验管理系统市场 - 产业分析

  • 驱动因素、限制因素和机会
    • 概述
    • 司机
    • 限制
    • 机会
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁
  • 价值链分析

第 12 章：附录

简介目录
Product Code: SR112024A18014

Japan clinical trials management system market size reached US$ 106.38 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 244.74 Million by 2032, exhibiting a growth rate (CAGR) of 9.10% during 2024-2032. The increasing prevalence of clinical trial complexity, involving larger datasets, multiple study sites, and intricate regulatory requirements, coupled with the rising need for system solutions to streamline trial management and ensure compliance, is primarily driving the market.

A clinical trials management system (CTMS) is a comprehensive software solution to optimize and streamline the management of clinical trials in the field of medical research. It serves as a centralized platform for researchers, sponsors, and study coordinators to plan, execute, and monitor all aspects of a clinical trial. CTMS facilitates efficient participant recruitment, tracks regulatory compliance, manages budgets and resources, and generates real-time reports for informed decision-making. It also enhances communication and collaboration among stakeholders, enabling seamless data sharing and documentation of trial activities. Key features of a CTMS typically include protocol management, patient enrollment and randomization, visit scheduling, data capture, adverse event tracking, and financial management. These systems are vital in ensuring data accuracy, protocol adherence, and regulatory compliance, ultimately accelerating the drug development process and improving patient safety. In summary, a CTMS plays a pivotal role in the successful execution of clinical trials by offering a centralized and organized approach to trial management, data collection, and reporting, thereby advancing medical research and healthcare innovation.

Japan Clinical Trials Management System Market Trends:

The clinical trials management system market in Japan is currently experiencing significant growth, driven by a combination of factors. Firstly, the increasing complexity of clinical trials necessitates advanced CTMS solutions. Consequently, pharmaceutical and biotechnology companies are adopting these systems to streamline their trial processes, enhancing efficiency and reducing operational costs. Furthermore, the growing emphasis on data integration and real-time analytics in clinical research has spurred CTMS adoption. As a result, CTMS solutions offer seamless integration with Electronic Health Records (EHRs) and other healthcare data sources, promoting better data-driven decision-making during trials. Moreover, regulatory agencies have imposed stringent compliance requirements, making it imperative for organizations to maintain accurate and up-to-date trial records. CTMS platforms provide a centralized repository for data and documentation, ensuring regulatory compliance and facilitating audits. Additionally, the regional expansion of clinical trials and the rise of virtual trials, which have increased the demand for systems with robust remote monitoring and patient engagement capabilities, is expected to drive the clinical trials management system market in Japan during the forecast period.

Japan Clinical Trials Management System Market Segmentation:

Component Insights:

  • Software
  • Services

Deployment Mode Insights:

  • Web-based CTMS
  • On-premises
  • Cloud-based CTMS

End User Insights:

  • Pharmaceutical and Biotechnology Firms
  • Contract Research Organizations
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan clinical trials management system market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan clinical trials management system market?
  • What is the breakup of the Japan clinical trials management system market on the basis of component?
  • What is the breakup of the Japan clinical trials management system market on the basis of deployment mode?
  • What is the breakup of the Japan clinical trials management system market on the basis of end user?
  • What are the various stages in the value chain of the Japan clinical trials management system market?
  • What are the key driving factors and challenges in the Japan clinical trials management system?
  • What is the structure of the Japan clinical trials management system market and who are the key players?
  • What is the degree of competition in the Japan clinical trials management system market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Clinical Trials Management System Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Clinical trials management system Market Landscape

  • 5.1 Historical and Current Market Trends (2018-2023)
  • 5.2 Market Forecast (2024-2032)

6 Japan Clinical Trials Management System Market - Breakup by Component

  • 6.1 Software
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2018-2023)
    • 6.1.3 Market Forecast (2024-2032)
  • 6.2 Services
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2018-2023)
    • 6.2.3 Market Forecast (2024-2032)

7 Japan Clinical Trials Management System Market - Breakup by Deployment Mode

  • 7.1 Web-based CTMS
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2018-2023)
    • 7.1.3 Market Forecast (2024-2032)
  • 7.2 On-premises
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2018-2023)
    • 7.2.3 Market Forecast (2024-2032)
  • 7.3 Cloud-based CTMS
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2018-2023)
    • 7.3.3 Market Forecast (2024-2032)

8 Japan Clinical Trials Management System Market - Breakup by End User

  • 8.1 Pharmaceutical and Biotechnology Firms
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2018-2023)
    • 8.1.3 Market Forecast (2024-2032)
  • 8.2 Contract Research Organizations
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2018-2023)
    • 8.2.3 Market Forecast (2024-2032)
  • 8.3 Others
    • 8.3.1 Historical and Current Market Trends (2018-2023)
    • 8.3.2 Market Forecast (2024-2032)

9 Japan Clinical Trials Management System Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Clinical Trials Management System Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix